Industry Research Reports
Home > Reports > Service & Software > Global Prenatal Second-Generation DNA Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Prenatal Second-Generation DNA Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-03-11
Pages: 151 Pages
Report ld: 6037648
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Prenatal Second-Generation DNA Sequencing Market Size(US$)
CAGR 2026-2032
10.9%
Market Size,2032
USD 1,842
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 988 million
Market Forecast in 2032(Value)
US$ 1,842 million
CAGR
10.9%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 897 million in 2025 to US$ 1842 million by 2032, at a CAGR of 10.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Prenatal Second-Generation DNA Sequencing refers to prenatal genetic testing that uses second-generation next-generation sequencing methods to generate DNA sequence information relevant to a pregnancy for screening or diagnostic assessment. It typically relies on high-throughput short-read sequencing and computational analysis to detect fetal genetic signals, interpret genomic variation, and produce clinically actionable results that guide follow-up testing and pregnancy management. The approach can be applied through noninvasive workflows that analyze fetal genetic material present in maternal blood as well as through sequencing of fetal or placental samples obtained via clinical procedures, with outputs delivered as structured reports designed to support medical decision making and genetic counseling.
Prenatal Second-Generation DNA Sequencing is becoming a central engine of modernization in prenatal care as health systems seek earlier, safer, and more information-rich assessment of fetal genetic risk. From a research report perspective, market momentum is driven by the scalability of high-throughput sequencing workflows, improving bioinformatics and laboratory automation, and a steady expansion of clinical use cases from core aneuploidy screening toward broader panels and, in selected high-risk pathways, more comprehensive sequencing-based diagnostics. Competitive dynamics are increasingly shaped by analytical performance in low fetal signal conditions, robustness of variant calling and classification, turnaround reliability, integration with clinician-friendly reporting and counseling pathways, and the ability to operate within tightening regulatory and reimbursement expectations. As adoption deepens, differentiation will continue to shift from basic sequencing capacity to end-to-end clinical governance and operational execution, favoring providers that can deliver consistent quality, strong interpretability, and scalable service networks across geographies.
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Prenatal Second-Generation DNA Sequencing market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Natera
- Labcorp
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- GeneDx
- PreventionGenetics
- SYNLAB
- Myriad Genetics
- GGA
- Fulgent Genetics
- Rainbow Genomics
- BillionToOne
- BGI Genomics
- Berry Genomics
- Annaroad
- Weihansi Biomedical Technology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Targeted Panels
- Exome Sequencing
- Others
Segment by Application
- Public Hospitals
- Private Hospitals
Segment by Category
- Non-Invasive
- Invasive
Segment by Division
- Public Health Program
- Consumer
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Prenatal Second-Generation DNA Sequencing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Prenatal Second-Generation DNA Sequencing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Targeted Panels
1.2.3 Exome Sequencing
1.2.4 Others
1.3 Market Segmentation by Invasiveness
1.3.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness, 2021 vs 2025 vs 2032
1.3.2 Non-Invasive
1.3.3 Invasive
1.4 Market Segmentation by Service Model
1.4.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Service Model, 2021 vs 2025 vs 2032
1.4.2 Public Health Program
1.4.3 Consumer
1.4.4 Others
1.5 Market Segmentation by Application
1.5.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Public Hospitals
1.5.3 Private Hospitals
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Prenatal Second-Generation DNA Sequencing Revenue Estimates and Forecasts (2021-2032)
2.2 Global Prenatal Second-Generation DNA Sequencing Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Prenatal Second-Generation DNA Sequencing Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Prenatal Second-Generation DNA Sequencing Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Targeted Panels: Market Share by Key Players
3.3.2 Exome Sequencing: Market Share by Key Players
3.3.3 Others: Market Share by Key Players
3.4 Global Prenatal Second-Generation DNA Sequencing Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Prenatal Second-Generation DNA Sequencing Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global Prenatal Second-Generation DNA Sequencing Market by Invasiveness
4.2.1 Global Revenue by Invasiveness (2021-2032)
4.2.2 Global Revenue-Based Market Share by Invasiveness (2021-2032)
4.3 Global Prenatal Second-Generation DNA Sequencing Market by Service Model
4.3.1 Global Revenue by Service Model (2021-2032)
4.3.2 Global Revenue-Based Market Share by Service Model (2021-2032)
4.4 Key Product Attributes and Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Prenatal Second-Generation DNA Sequencing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Prenatal Second-Generation DNA Sequencing Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Prenatal Second-Generation DNA Sequencing Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Natera
11.1.1 Natera Corporation Information
11.1.2 Natera Business Overview
11.1.3 Natera Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.1.4 Natera Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.1.5 Natera Prenatal Second-Generation DNA Sequencing Revenue by Product in 2025
11.1.6 Natera Prenatal Second-Generation DNA Sequencing Revenue by Application in 2025
11.1.7 Natera Prenatal Second-Generation DNA Sequencing Revenue by Geographic Area in 2025
11.1.8 Natera Prenatal Second-Generation DNA Sequencing SWOT Analysis
11.1.9 Natera Recent Developments
11.2 Labcorp
11.2.1 Labcorp Corporation Information
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.2.4 Labcorp Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.2.5 Labcorp Prenatal Second-Generation DNA Sequencing Revenue by Product in 2025
11.2.6 Labcorp Prenatal Second-Generation DNA Sequencing Revenue by Application in 2025
11.2.7 Labcorp Prenatal Second-Generation DNA Sequencing Revenue by Geographic Area in 2025
11.2.8 Labcorp Prenatal Second-Generation DNA Sequencing SWOT Analysis
11.2.9 Labcorp Recent Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Corporation Information
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.3.4 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.3.5 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue by Product in 2025
11.3.6 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue by Application in 2025
11.3.7 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue by Geographic Area in 2025
11.3.8 Quest Diagnostics Prenatal Second-Generation DNA Sequencing SWOT Analysis
11.3.9 Quest Diagnostics Recent Developments
11.4 MedGenome
11.4.1 MedGenome Corporation Information
11.4.2 MedGenome Business Overview
11.4.3 MedGenome Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.4.4 MedGenome Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.4.5 MedGenome Prenatal Second-Generation DNA Sequencing Revenue by Product in 2025
11.4.6 MedGenome Prenatal Second-Generation DNA Sequencing Revenue by Application in 2025
11.4.7 MedGenome Prenatal Second-Generation DNA Sequencing Revenue by Geographic Area in 2025
11.4.8 MedGenome Prenatal Second-Generation DNA Sequencing SWOT Analysis
11.4.9 MedGenome Recent Developments
11.5 Mayo Clinic Laboratories
11.5.1 Mayo Clinic Laboratories Corporation Information
11.5.2 Mayo Clinic Laboratories Business Overview
11.5.3 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.5.4 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.5.5 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue by Product in 2025
11.5.6 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue by Application in 2025
11.5.7 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue by Geographic Area in 2025
11.5.8 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing SWOT Analysis
11.5.9 Mayo Clinic Laboratories Recent Developments
11.6 GeneDx
11.6.1 GeneDx Corporation Information
11.6.2 GeneDx Business Overview
11.6.3 GeneDx Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.6.4 GeneDx Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.6.5 GeneDx Recent Developments
11.7 PreventionGenetics
11.7.1 PreventionGenetics Corporation Information
11.7.2 PreventionGenetics Business Overview
11.7.3 PreventionGenetics Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.7.4 PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.7.5 PreventionGenetics Recent Developments
11.8 SYNLAB
11.8.1 SYNLAB Corporation Information
11.8.2 SYNLAB Business Overview
11.8.3 SYNLAB Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.8.4 SYNLAB Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.8.5 SYNLAB Recent Developments
11.9 Myriad Genetics
11.9.1 Myriad Genetics Corporation Information
11.9.2 Myriad Genetics Business Overview
11.9.3 Myriad Genetics Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.9.4 Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.9.5 Myriad Genetics Recent Developments
11.10 GGA
11.10.1 GGA Corporation Information
11.10.2 GGA Business Overview
11.10.3 GGA Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.10.4 GGA Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Fulgent Genetics
11.11.1 Fulgent Genetics Corporation Information
11.11.2 Fulgent Genetics Business Overview
11.11.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.11.4 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.11.5 Fulgent Genetics Recent Developments
11.12 Rainbow Genomics
11.12.1 Rainbow Genomics Corporation Information
11.12.2 Rainbow Genomics Business Overview
11.12.3 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.12.4 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.12.5 Rainbow Genomics Recent Developments
11.13 BillionToOne
11.13.1 BillionToOne Corporation Information
11.13.2 BillionToOne Business Overview
11.13.3 BillionToOne Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.13.4 BillionToOne Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.13.5 BillionToOne Recent Developments
11.14 BGI Genomics
11.14.1 BGI Genomics Corporation Information
11.14.2 BGI Genomics Business Overview
11.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.14.4 BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.14.5 BGI Genomics Recent Developments
11.15 Berry Genomics
11.15.1 Berry Genomics Corporation Information
11.15.2 Berry Genomics Business Overview
11.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.15.4 Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.15.5 Berry Genomics Recent Developments
11.16 Annaroad
11.16.1 Annaroad Corporation Information
11.16.2 Annaroad Business Overview
11.16.3 Annaroad Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.16.4 Annaroad Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.16.5 Annaroad Recent Developments
11.17 Weihansi Biomedical Technology
11.17.1 Weihansi Biomedical Technology Corporation Information
11.17.2 Weihansi Biomedical Technology Business Overview
11.17.3 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product Features and Attributes
11.17.4 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
11.17.5 Weihansi Biomedical Technology Recent Developments
12 Prenatal Second-Generation DNA Sequencing Value Chain and Ecosystem Analysis
12.1 Prenatal Second-Generation DNA Sequencing Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Prenatal Second-Generation DNA Sequencing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Prenatal Second-Generation DNA Sequencing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Invasiveness, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Service Model, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Prenatal Second-Generation DNA Sequencing Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Prenatal Second-Generation DNA Sequencing Revenue by Region (US$ Million), 2021-2026
Table 7. Global Prenatal Second-Generation DNA Sequencing Revenue by Region (US$ Million), 2027-2032
Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 9. Global Prenatal Second-Generation DNA Sequencing Revenue by Players (US$ Million), 2021-2026
Table 10. Global Prenatal Second-Generation DNA Sequencing Revenue-Based Market Share by Players (2021-2026)
Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Prenatal Second-Generation DNA Sequencing Revenue, 2025
Table 13. Global Prenatal Second-Generation DNA Sequencing Average Gross Margin (%) by Player (2021 vs 2025)
Table 14. Global Prenatal Second-Generation DNA Sequencing Companies Headquarters
Table 15. Global Prenatal Second-Generation DNA Sequencing Market Concentration Ratio (CR5)
Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 18. Global Prenatal Second-Generation DNA Sequencing Revenue by Type (US$ Million), 2021-2026
Table 19. Global Prenatal Second-Generation DNA Sequencing Revenue by Type (US$ Million), 2027-2032
Table 20. Global Prenatal Second-Generation DNA Sequencing Revenue by Invasiveness (US$ Million), 2021-2026
Table 21. Global Prenatal Second-Generation DNA Sequencing Revenue by Invasiveness (US$ Million), 2027-2032
Table 22. Global Prenatal Second-Generation DNA Sequencing Revenue by Service Model (US$ Million), 2021-2026
Table 23. Global Prenatal Second-Generation DNA Sequencing Revenue by Service Model (US$ Million), 2027-2032
Table 24. Key Product Attributes and Differentiation
Table 25. Global Prenatal Second-Generation DNA Sequencing Revenue by Application (US$ Million), 2021-2026
Table 26. Global Prenatal Second-Generation DNA Sequencing Revenue by Application (US$ Million), 2027-2032
Table 27. Prenatal Second-Generation DNA Sequencing High-Growth Sectors Demand CAGR (2026-2032)
Table 28. Top Customers by Region
Table 29. Top Customers by Application
Table 30. North America Prenatal Second-Generation DNA Sequencing Growth Accelerators and Market Barriers
Table 31. North America Prenatal Second-Generation DNA Sequencing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Europe Prenatal Second-Generation DNA Sequencing Growth Accelerators and Market Barriers
Table 33. Europe Prenatal Second-Generation DNA Sequencing Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Asia-Pacific Prenatal Second-Generation DNA Sequencing Growth Accelerators and Market Barriers
Table 35. Asia-Pacific Prenatal Second-Generation DNA Sequencing Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Central and South America Prenatal Second-Generation DNA Sequencing Investment Opportunities and Key Challenges
Table 37. Central and South America Prenatal Second-Generation DNA Sequencing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 38. Middle East and Africa Prenatal Second-Generation DNA Sequencing Investment Opportunities and Key Challenges
Table 39. Middle East and Africa Prenatal Second-Generation DNA Sequencing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 40. Natera Corporation Information
Table 41. Natera Description and Major Businesses
Table 42. Natera Product Features and Attributes
Table 43. Natera Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. Natera Revenue Proportion by Product in 2025
Table 45. Natera Revenue Proportion by Application in 2025
Table 46. Natera Revenue Proportion by Geographic Area in 2025
Table 47. Natera Prenatal Second-Generation DNA Sequencing SWOT Analysis
Table 48. Natera Recent Developments
Table 49. Labcorp Corporation Information
Table 50. Labcorp Description and Major Businesses
Table 51. Labcorp Product Features and Attributes
Table 52. Labcorp Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Labcorp Revenue Proportion by Product in 2025
Table 54. Labcorp Revenue Proportion by Application in 2025
Table 55. Labcorp Revenue Proportion by Geographic Area in 2025
Table 56. Labcorp Prenatal Second-Generation DNA Sequencing SWOT Analysis
Table 57. Labcorp Recent Developments
Table 58. Quest Diagnostics Corporation Information
Table 59. Quest Diagnostics Description and Major Businesses
Table 60. Quest Diagnostics Product Features and Attributes
Table 61. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Quest Diagnostics Revenue Proportion by Product in 2025
Table 63. Quest Diagnostics Revenue Proportion by Application in 2025
Table 64. Quest Diagnostics Revenue Proportion by Geographic Area in 2025
Table 65. Quest Diagnostics Prenatal Second-Generation DNA Sequencing SWOT Analysis
Table 66. Quest Diagnostics Recent Developments
Table 67. MedGenome Corporation Information
Table 68. MedGenome Description and Major Businesses
Table 69. MedGenome Product Features and Attributes
Table 70. MedGenome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. MedGenome Revenue Proportion by Product in 2025
Table 72. MedGenome Revenue Proportion by Application in 2025
Table 73. MedGenome Revenue Proportion by Geographic Area in 2025
Table 74. MedGenome Prenatal Second-Generation DNA Sequencing SWOT Analysis
Table 75. MedGenome Recent Developments
Table 76. Mayo Clinic Laboratories Corporation Information
Table 77. Mayo Clinic Laboratories Description and Major Businesses
Table 78. Mayo Clinic Laboratories Product Features and Attributes
Table 79. Mayo Clinic Laboratories Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Mayo Clinic Laboratories Revenue Proportion by Product in 2025
Table 81. Mayo Clinic Laboratories Revenue Proportion by Application in 2025
Table 82. Mayo Clinic Laboratories Revenue Proportion by Geographic Area in 2025
Table 83. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing SWOT Analysis
Table 84. Mayo Clinic Laboratories Recent Developments
Table 85. GeneDx Corporation Information
Table 86. GeneDx Description and Major Businesses
Table 87. GeneDx Product Features and Attributes
Table 88. GeneDx Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. GeneDx Recent Developments
Table 90. PreventionGenetics Corporation Information
Table 91. PreventionGenetics Description and Major Businesses
Table 92. PreventionGenetics Product Features and Attributes
Table 93. PreventionGenetics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 94. PreventionGenetics Recent Developments
Table 95. SYNLAB Corporation Information
Table 96. SYNLAB Description and Major Businesses
Table 97. SYNLAB Product Features and Attributes
Table 98. SYNLAB Revenue (US$ Million) and Gross Margin (2021-2026)
Table 99. SYNLAB Recent Developments
Table 100. Myriad Genetics Corporation Information
Table 101. Myriad Genetics Description and Major Businesses
Table 102. Myriad Genetics Product Features and Attributes
Table 103. Myriad Genetics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 104. Myriad Genetics Recent Developments
Table 105. GGA Corporation Information
Table 106. GGA Description and Major Businesses
Table 107. GGA Product Features and Attributes
Table 108. GGA Revenue (US$ Million) and Gross Margin (2021-2026)
Table 109. GGA Recent Developments
Table 110. Fulgent Genetics Corporation Information
Table 111. Fulgent Genetics Description and Major Businesses
Table 112. Fulgent Genetics Product Features and Attributes
Table 113. Fulgent Genetics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 114. Fulgent Genetics Recent Developments
Table 115. Rainbow Genomics Corporation Information
Table 116. Rainbow Genomics Description and Major Businesses
Table 117. Rainbow Genomics Product Features and Attributes
Table 118. Rainbow Genomics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 119. Rainbow Genomics Recent Developments
Table 120. BillionToOne Corporation Information
Table 121. BillionToOne Description and Major Businesses
Table 122. BillionToOne Product Features and Attributes
Table 123. BillionToOne Revenue (US$ Million) and Gross Margin (2021-2026)
Table 124. BillionToOne Recent Developments
Table 125. BGI Genomics Corporation Information
Table 126. BGI Genomics Description and Major Businesses
Table 127. BGI Genomics Product Features and Attributes
Table 128. BGI Genomics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 129. BGI Genomics Recent Developments
Table 130. Berry Genomics Corporation Information
Table 131. Berry Genomics Description and Major Businesses
Table 132. Berry Genomics Product Features and Attributes
Table 133. Berry Genomics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 134. Berry Genomics Recent Developments
Table 135. Annaroad Corporation Information
Table 136. Annaroad Description and Major Businesses
Table 137. Annaroad Product Features and Attributes
Table 138. Annaroad Revenue (US$ Million) and Gross Margin (2021-2026)
Table 139. Annaroad Recent Developments
Table 140. Weihansi Biomedical Technology Corporation Information
Table 141. Weihansi Biomedical Technology Description and Major Businesses
Table 142. Weihansi Biomedical Technology Product Features and Attributes
Table 143. Weihansi Biomedical Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 144. Weihansi Biomedical Technology Recent Developments
Table 145. Technologies, Platforms and Infrastructure
Table 146. Distributors List
Table 147. Market Trends and Market Evolution
Table 148. Market Drivers and Opportunities
Table 149. Market Challenges, Risks, and Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Targeted Panels Product Picture
Figure 3. Exome Sequencing Product Picture
Figure 4. Others Product Picture
Figure 5. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Invasiveness, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Non-Invasive Product Picture
Figure 7. Invasive Product Picture
Figure 8. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Service Model, 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Public Health Program Product Picture
Figure 10. Consumer Product Picture
Figure 11. Others Product Picture
Figure 12. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Public Hospitals
Figure 14. Private Hospitals
Figure 15. Prenatal Second-Generation DNA Sequencing Report Years Considered
Figure 16. Global Prenatal Second-Generation DNA Sequencing Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 18. Global Prenatal Second-Generation DNA Sequencing Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 19. Global Prenatal Second-Generation DNA Sequencing Revenue-Based Market Share by Region (2021-2032)
Figure 20. Global Prenatal Second-Generation DNA Sequencing Revenue-Based Market Share Ranking (2025)
Figure 21. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 22. Targeted Panels Revenue-Based Market Share by Player in 2025
Figure 23. Exome Sequencing Revenue-Based Market Share by Player in 2025
Figure 24. Others Revenue-Based Market Share by Player in 2025
Figure 25. Global Prenatal Second-Generation DNA Sequencing Revenue-Based Market Share by Type (2021-2032)
Figure 26. Global Prenatal Second-Generation DNA Sequencing Revenue-Based Market Share by Invasiveness (2021-2032)
Figure 27. Global Prenatal Second-Generation DNA Sequencing Revenue-Based Market Share by Service Model (2021-2032)
Figure 28. Global Prenatal Second-Generation DNA Sequencing Revenue-Based Market Share by Application (2021-2032)
Figure 29. North America Prenatal Second-Generation DNA Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 30. North America Top 5 Players Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) in 2025
Figure 31. North America Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 32. US Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 33. Canada Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 34. Mexico Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 35. Europe Prenatal Second-Generation DNA Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 36. Europe Top 5 Players Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) in 2025
Figure 37. Europe Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 38. Germany Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 39. France Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 40. U.K. Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 41. Italy Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 42. Russia Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 43. Asia-Pacific Prenatal Second-Generation DNA Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 44. Asia-Pacific Top 8 Players Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) in 2025
Figure 45. Asia-Pacific Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 46. Indonesia Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 47. Japan Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 48. South Korea Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 49. Australia Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 50. India Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 51. Indonesia Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 52. Vietnam Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 53. Malaysia Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 54. Philippines Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 55. Singapore Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 56. Central and South America Prenatal Second-Generation DNA Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 57. Central and South America Top 5 Players Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) in 2025
Figure 58. Central and South America Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 59. Brazil Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 60. Argentina Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 61. Middle East and Africa Prenatal Second-Generation DNA Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 62. Middle East and Africa Top 5 Players Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) in 2025
Figure 63. Middle East and Africa Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 64. GCC Countries Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 65. Israel Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 66. Egypt Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 67. South Africa Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021-2032
Figure 68. Prenatal Second-Generation DNA Sequencing Value Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Prenatal Second-Generation DNA Sequencing market size from 2026 to 2032?
The annual compound growth rate of the global Prenatal Second-Generation DNA Sequencing market is 10.9% 2026 to 2032.
Which region is expected to have the highest market share?
Which companies rank high in the global Prenatal Second-Generation DNA Sequencing market?
What was the global market size of Prenatal Second-Generation DNA Sequencing in 2026?
What was the global market size of Prenatal Second-Generation DNA Sequencing in 2032?
Related Reports
Global Prenatal Second-Generation DNA Sequencing Market Research Report 2026
The global Prenatal Second-Generation DNA Sequencing market was valued at US$ 897 million in 2025 and is anticipated to reach US$ 1842 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 130
USD 2900.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Prenatal Second-Generation DNA Sequencing market size was US$ 897 million in 2025 and is forecast to reach a readjusted size of US$ 1842 million by 2032 with a CAGR of 10.9% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 106
USD 4250.00
(Single User License)
Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 897 million in 2025 and is projected to reach US$ 1842 million, growing at a CAGR of 10.9% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 121
USD 3950.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Research Report 2025
The global market for Prenatal Second-Generation DNA Sequencing was valued at US$ 1290 million in the year 2024 and is projected to reach a revised size of US$ 2458 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published Date: 2025-04-13
Pages: 108
USD 2900.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Prenatal Second-Generation DNA Sequencing market size was US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 117
USD 4250.00
(Single User License)
Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 160
USD 3950.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Insights, Forecast to 2031
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 1414 million in 2025 to US$ 2458 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.7% during the forecast period.
Published Date: 2025-04-13
Pages: 166
USD 4900.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Research Report 2026
The global Prenatal Second-Generation DNA Sequencing market was valued at US$ 897 million in 2025 and is anticipated to reach US$ 1842 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published: 2026-03-11
Pages: 130
USD 2900.00 (Single User License)Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Prenatal Second-Generation DNA Sequencing market size was US$ 897 million in 2025 and is forecast to reach a readjusted size of US$ 1842 million by 2032 with a CAGR of 10.9% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 106
USD 4250.00 (Single User License)Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 897 million in 2025 and is projected to reach US$ 1842 million, growing at a CAGR of 10.9% from 2026 to 2032.
Published: 2026-03-09
Pages: 121
USD 3950.00 (Single User License)Global Prenatal Second-Generation DNA Sequencing Market Research Report 2025
The global market for Prenatal Second-Generation DNA Sequencing was valued at US$ 1290 million in the year 2024 and is projected to reach a revised size of US$ 2458 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published: 2025-04-13
Pages: 108
USD 2900.00 (Single User License)Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Prenatal Second-Generation DNA Sequencing market size was US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 117
USD 4250.00 (Single User License)Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 160
USD 3950.00 (Single User License)Global Prenatal Second-Generation DNA Sequencing Market Insights, Forecast to 2031
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 1414 million in 2025 to US$ 2458 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.7% during the forecast period.
Published: 2025-04-13
Pages: 166
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now